Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Public ClinicalTrials.gov record NCT01624246. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Multicenter, Open-label, Single-dose Study to Assess the Pharmacokinetics of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the pharmacokinetic (PK) profiles of ceftaroline and avibactam in adults with augmented renal clearance (ARC).
Study identification
- NCT ID
- NCT01624246
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 12 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2012 (Type not available)
- Primary completion
- Mar 2013 (Actual)
- Completion
- Mar 2013 (Actual)
- Last update posted
- Apr 7, 2017
2012 – 2013
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Fresno | California | 93711 | — |
| Investigational Site | Los Angeles | California | 90033 | — |
| Investigational Site | San Diego | California | 92123 | — |
| Investigational Site | Stanford | California | 94605 | — |
| Investigational Site | Hartford | Connecticut | 06102 | — |
| Investigational Site | Washington D.C. | District of Columbia | 20010 | — |
| Investigational Site | Gainesville | Florida | 32610 | — |
| Investigational Site | Miami | Florida | 33136 | — |
| Investigational Site | Chicago | Illinois | 60612 | — |
| Investigational Site | Maywood | Illinois | 60153 | — |
| Investigational Site | Peoria | Illinois | 61606 | — |
| Investigational Site | Duluth | Minnesota | 55805 | — |
| Investigational Site | Omaha | Nebraska | 68131 | — |
| Investigational Site | Neptune City | New Jersey | 07753 | — |
| Investigational Site | Winston-Salem | North Carolina | 27157 | — |
| Investigational Site | Cleveland | Ohio | 44106 | — |
| Investigational Site | Columbus | Ohio | 43210 | — |
| Investigational Site | Dayton | Ohio | 45409 | — |
| Investigational Site | Houston | Texas | 77401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01624246, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01624246 live on ClinicalTrials.gov.